The money will be used to further develop core technologies and product platforms in two of Adventus' portfolio companies, Allevion Therapeutics and Pressao Medical. Part of a $10M Series A fund-raising effort.
OnFace SDC A $250M diversified technology company with global leadership in Internet of Things (IoT), artificial intelligence (AI), and integrated systems.
